Study characteristics. by Zhuoyang Xia (21354186)

“…We excluded non-randomized trials, studies without full texts, unrelated interventions, and those not reporting relevant outcomes. …”

Flowchart of literature retrieval. by Zhuoyang Xia (21354186)

“…We excluded non-randomized trials, studies without full texts, unrelated interventions, and those not reporting relevant outcomes. …”

Data extraction. by Zhuoyang Xia (21354186)

“…We excluded non-randomized trials, studies without full texts, unrelated interventions, and those not reporting relevant outcomes. …”

Cochrane Collaboration’s risk of bias tool. by Zhuoyang Xia (21354186)

“…We excluded non-randomized trials, studies without full texts, unrelated interventions, and those not reporting relevant outcomes. …”

The volume of the right (red) and left (blue) IC are shown as a function of age on a logarithmic scale. by Pingling Kwok (14896191)

Supplementary data. by Malte Ostendarp (13217973)

“…In contrast, the addition of hydrogen at 26 °C caused a significant decrease in the photophysiology of both <i>Acropora</i> sp. and <i>P. verrucosa</i>. …”

Negative (Prednisone) and basal (ATP) control compounds binding to ALK protein. by Richard Junior Zapata Dongo (17912565)

S1 Data - by Richard Junior Zapata Dongo (17912565)

“…This interaction was further supported by a significant decrease of ALK phosphorylation in single and combination treatment with 300nM ABT-199. …”

Molecular docking showed that ABT-199 can fit into active site of ALK^Mutant. by Richard Junior Zapata Dongo (17912565)

RNA targets of Mod identified by RiP-Seq. by Amalia S. Parra (4173004)

“…Mod is expressed in larval brains and its loss leads to a significant decrease in the number of central brain NBs. …”

Amino acids interactions and binding energy describe that ABT-199 binds to ALK^Mutant. by Richard Junior Zapata Dongo (17912565)

The binding energy values of ATP, ALK inhibitors and ABT-199 to ALK were obtained from AlphaFold and modeled protein structures. by Richard Junior Zapata Dongo (17912565)

Discovery of NP3-742: A Structurally Diverse NLRP3 Inhibitor Identified through an Unusual Phenol Replacement by Juraj Velcicky (2201350)

“…Initial indole analog <b>7</b> demonstrated a robust in vivo IL-1β inhibition, but also a significant hERG inhibition. …”

Discovery of NP3-742: A Structurally Diverse NLRP3 Inhibitor Identified through an Unusual Phenol Replacement by Juraj Velcicky (2201350)

“…Initial indole analog <b>7</b> demonstrated a robust in vivo IL-1β inhibition, but also a significant hERG inhibition. …”

Discovery of NP3-742: A Structurally Diverse NLRP3 Inhibitor Identified through an Unusual Phenol Replacement by Juraj Velcicky (2201350)

“…Initial indole analog <b>7</b> demonstrated a robust in vivo IL-1β inhibition, but also a significant hERG inhibition. …”

<i>In vivo</i> treatment decreases bacterial burden and colonization of vital organs in a skin abscess biofilm infection model. by Robert L. Beckman I.V (22784303)

Comparative death probabilities of tumor-bearing mice across weeks of assessment. by Robert Botelho (20308297)

Changepoint analysis in comparison of MarBTN-specific eDNA and cancer in hemolymph. by Rachael M. Giersch (22331947)

<i>shk-1</i> mutants display decreased glycogen storage. by Longjun Pu (20685717)

Pan-cancer analyses of ANGPTL4 expression and its prognostic significance in the TCGA database. by Yu Zhang (12946)